Table 4 The comparison of genotypic and allelic frequencies of both SNPs between early/late-onset PE and control groups.
From: Evaluation of Glutathione Peroxidase 4 role in Preeclampsia
Group | N | rs713041 | rs4807542 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CC | CT | TT | C | T | AA | AG | GG | A | G | ||
Early-onset PE | 523 | 181 | 253 | 89 | 615 | 431 | 12 | 105 | 406 | 129 | 917 |
Control | 1386 | 402 | 661 | 323 | 1465 | 1307 | 20 | 286 | 1080 | 326 | 2446 |
χ2 | 10.896 | 10.825 | 1.704 | 0.237 | |||||||
p-value | 0.004 | 0.001 | 0.427 | 0.615 | |||||||
OR | 1.273 | 1.056 | |||||||||
95% CI | 1.102–1.470 | 0.849–1.312 | |||||||||
Late-onset PE | 485 | 152 | 244 | 89 | 548 | 422 | 7 | 83 | 395 | 97 | 873 |
Control | 1386 | 402 | 661 | 323 | 1465 | 1307 | 20 | 286 | 1080 | 326 | 2446 |
χ2 | 5.175 | 3.841 | 2.824 | 2.221 | |||||||
p-value | 0.075 | 0.052 | 0.244 | 0.136 | |||||||
OR | 1.159 | 0.834 | |||||||||
95% CI | 1.000–1.342 | 0.656–1.059 | |||||||||
